CLINICAL_TRIALS
ClinicalTrials.gov record update
Phase 1 Study to Determine the Safety and Efficacy of Onvansertib, A Novel, Oral, PLK1 Inhibitor in Patients With Proliferative Chronic Myelomonocytic Leukemia (CMML) and Myelodysplastic Syndrome/MPN Overlap Neoplasms Relapsed/Refractory or Intolerant to Available Therapies
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT05549661
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-25T22:28:23.253815+00:00
- Published At
- 2026-02-23T00:00:00+00:00
- Record Updated At
- 2026-02-23
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Recurrent Chronic Myelomonocytic Leukemia", "Refractory Chronic Myelomonocytic Leukemia", "Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified", "Recurrent Atypical Chronic Myeloid Leukemia", "Recurrent Myelodysplastic/Myeloproliferative Neoplasm", "Refractory Myelodysplastic/Myeloproliferative Neoplasm"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-02-23"- protocolSection.identificationModule.nctId
"NCT05549661"- protocolSection.identificationModule.officialTitle
"Phase 1 Study to Determine the Safety and Efficacy of Onvansertib, A Novel, Oral, PLK1 Inhibitor in Patients With Proliferative Chronic Myelomonocytic Leukemia (CMML) and Myelodysplastic Syndrome/MPN Overlap Neoplasms Relapsed/Refractory or Intolerant to Available Therapies"- protocolSection.statusModule.overallStatus
"RECRUITING"- protocolSection.designModule.phases
["PHASE1"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.